Search Results 1051-1060 of 17896 for Assay

  1. First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) - Mayo Clinic

    Free light chain (FLC) assay with involved FLC level ≥10 mg/dL with an abnormal serum FLC ratio - A patient with Immunoglobulin A (IgA) myeloma but without ...

  2. Diarrhea Clinical Trials - Mayo Clinic Research

    The investigators aim to study the ability of the HPLC assay for fecal bile acids to demonstrate responsiveness after treatment with Colesevelam. A Study of ...

  3. Study Investigating the Activity of Vidofludimus Calcium as a Treatment for Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    HIV/AIDS (per medical record or HIVAb/HIV antigen) , tuberculosis, or positive interferon-gamma assay (IGRAs) for Mycobacterium tuberculosis. Other ...

  4. Hepatitis C Therapeutic Registry and Research Network - Mayo Clinic

    Studies comparing HCV RNA assays are not considered exclusionary. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

  5. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

    Local laboratory testing using next generation sequencing [NGS], fluorescence in situ hybridization [FISH], or other assays that can determine FGFR2 gene ...

  6. A Trial of Felzartamab in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR) - Mayo Clinic

    ... assays within 6 months prior to randomization. Key Exclusion Criteria: * Transplant: Blood type (ABO)-incompatible transplant. * History of multiple organ ...

  7. Stomach Cancer Clinical Trials - Mayo Clinic Research

    ... assays using patient peripheral blood immune cells or serum. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal ...

  8. Infectious Diseases Clinical Trials - Mayo Clinic Research

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  9. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

    Has laboratory-confirmed (within 14 days prior to enrollment) SARS-CoV-2 infection as determined by PCR or other commercial or public health assay in any ...

  10. Services - Genome Analysis Core - Mayo Clinic Research

    Equipment. Tecan Roma (3) liquid handlers for Illumina Infinium BeadArray assays with autoloaders (2). Illumina iScan (4) scanners for Illumina ...